Professional Documents
Culture Documents
(Download PDF) Goodwin and Guzes Psychiatric Diagnosis 7Th Edition Full Chapter PDF
(Download PDF) Goodwin and Guzes Psychiatric Diagnosis 7Th Edition Full Chapter PDF
https://ebookmass.com/product/goodwin-and-guzes-psychiatric-
diagnosis-7th-edition-carol-s-north/
https://ebookmass.com/product/psychiatric-drugs-
explained-7th-7th-edition-david-healy/
https://ebookmass.com/product/psychiatric-drugs-explained-7th-
edition-healy/
https://ebookmass.com/product/stroke-pathophysiology-diagnosis-
and-management-7th-edition-james-grotta/
Differential Diagnosis of Common Complaints 7th Edition
https://ebookmass.com/product/differential-diagnosis-of-common-
complaints-7th-edition/
https://ebookmass.com/product/stroke-pathophysiology-diagnosis-
and-management-7e-2021-7th-edition-james-grotta/
https://ebookmass.com/product/queen-of-night-the-thorne-
hill-6-1st-edition-emily-goodwin-goodwin/
https://ebookmass.com/product/differential-diagnosis-of-common-
complaints-7th-edition-robert-h-seller/
https://ebookmass.com/product/zitelli-and-davis-atlas-of-
pediatric-physical-diagnosis-7th-edition-ebook-pdf-version/
I N ME MOR I U M
ELI ROBINS
Who, as much as any one person, launched a new era in American psychiatry
SAMUEL B. GUZE
The tough-minded individual who believed that there was only one model
of psychiatry: the medical model—which must be part of the mainstream
of modern medicine
DON GOODWIN
Gifted writer and co-author of editions two through five
( vii )
CON T E N T S
3. Schizophrenic Disorders 61
Index 377
( ix )
PR EFAC E TO T H E S E V E N T H E DI T ION
Forty-four years have elapsed since this text was first published. Over this
time period, psychiatry has clearly evolved along three noteworthy lines.
First, most psychiatrists have become diagnosticians. The groundwork
was set for this in no small part by the authors and collaborators of the
early versions of this text, including Eli Robins, Robert A. Woodruff, Donald
W. Goodwin, and Samuel B. Guze at Washington University in St. Louis.
In particular, their two-pronged philosophical approach to psychiatric ill-
ness/diagnosis was to be “agnostic” about the origin of a mental illness
and to draw psychiatric conclusions (including diagnostic criteria) based
on reliable, reproducible data. The early studies of this group of psychiatric
researchers from the 1960s and 1970s eventually produced formal oper-
ational criteria sets for the 12 major mental illnesses (adapted from “the
Feighner criteria”) (11). While this overall approach to psychiatric illness
was described as “narrow” by some (and less charitably by others) in main-
stream psychiatry at the time, the criteria sets formed the early basis for
a common language among psychiatrists. The diagnostic approach used an
“atheoretical” basis for the origin of psychiatric illness, drawing conclusions
and developing criteria based on scientific evidence. This approach gained
much wider acceptance (and general acceptance by the field) after publica-
tion of the best-selling DSM-III (Diagnostic and Statistical Manual of Mental
Disorders, 3rd edition, of the American Psychiatric Association) (2) in
1980. The “similarities” between the DSM-III and Washington University
approaches were not surprising, as the authors noted earlier were among
the DSM-III taskforce contributors, and one-third of the overall taskforce
members had trained at Washington University.
Ultimately, the DSM-III solidified a widely acceptable common language
and explicit criteria for the major mental illnesses as had long been used in
most other areas of medicine. Frustrated by the unknown etiology of most
major psychiatric illnesses, young scientifically trained physicians could rely
on a published framework as a foundation for communication, research,
( xi )
( xii ) Preface to the Seventh Edition
metabolic functions. Arising from this early excitement and frank hu-
bris was the notion that neuroscience, imaging, and genetics would yield
answers, presumably in short order. The architects of DSM-5 promised in-
clusion of these “findings” to support the outstanding questions of validity
of the major mental disorders. (Also promised by the Task Force for DSM-5
was a dimensional approach to psychiatric diagnosis.)
As the scientific findings failed to materialize and complexities of the
tasks expanded beyond current capabilities (dimensionalism without
reconciling increasing comorbidity risks), various stakeholders began
raising questions. Perhaps the most damning criticism—immediately prior
to the 2013 introduction of DSM-5—was a direct rebuke by the National
Institute of Mental Health (NIMH) that not only constituted a major
funding source for the DSM series but also provided indirect support by
requiring DSM language in formal NIMH grant applications.
The failure to identify a single basis for any major (or minor) mental ill-
ness accompanied DSM-5’s departure from the careful iterative style of the
DSM series (DSM-III-R to DSM-IV-TR) that introduced abrupt major struc-
tural changes, acceptance of poor agreement within criteria, ill-conceived
theoretical changes, and overly broadening criteria. These missteps and
errors have come to light over the ensuing years with the application of
DSM-5 criteria particularly to issues within government, insurance, clinical
practice, research, and society.
Space does not permit comprehensive review of all of the major changes
to the criteria in DSM-5, but some high points may assist the reader. Perhaps
most problematic for the acceptance (and credibility) of DSM-5 (and, by di-
rect extension, psychiatry) were major structural changes in the approach
to diagnoses, particularly removal of the multi- axial system without
much empirical basis or guidance. Over the last 33 years, probably 90% of
practicing psychiatrists, as well as many more allied health professionals,
were educated under the DSM system of psychiatric diagnosis. Users of
the DSM-5 were told that the manual had moved to non-axial documen-
tation of diagnosis, by removing Axes I–III, which were “combined,” and
that impinging social and situational factors and functional impairments
should be notated. No elaboration was provided on newly created issues for
addressing diagnostic primacy, including definition of primary versus sec-
ondary disorders (i.e., first onset versus focus of treatment), formal con-
sideration of how the diagnoses integrate in the DSM-5 list format, and
determination of amount of overall functional impact on the individual—
complexities which had been addressed in previous editions of the criteria.
Problematic for research was the poor interrater reliability (whether two
examiners of the same case agree or disagree on the diagnosis) of many
( xiv ) Preface to the Seventh Edition
( xvii )
( xviii ) Preface to the First Edition
have come and gone, some more useful than others, and there is no guar-
antee that our present “disease”—medical or psychiatric—will represent
the same clusters of symptoms and signs a hundred years from now that
they do today. On the contrary, as more is learned, more useful clusters
surely will emerge.
There are few explanations in this book. This is because for most psy-
chiatric conditions there are no explanations. “Etiology unknown” is
the hallmark of psychiatry as well as its bane. Historically, once etiology
is known, a disease stops being “psychiatric.” Vitamins were discovered,
whereupon vitamin-deficiency psychiatric disorders no longer were treated
by psychiatrists. The spirochete was found, then penicillin, and neurosyph-
ilis, once a major psychiatric disorder, became one more infection treated
by nonpsychiatrists.
Little, however, is really known about most medical illnesses. Even in-
fectious diseases remain puzzles in that some infected individuals have
symptoms and others do not.
People continue to speculate about etiology, of course, and this is good
if it produces testable hypotheses and bad if speculation is mistaken for
truth. In this book, speculation largely is avoided, since it is available so
plentifully elsewhere.
A final word about this approach to psychiatry. It is sometimes called
“organic.” This is misleading. A better term, perhaps, is “agnostic.” Without
evidence, we do not believe pills are better than words. Without evidence,
we do not believe chemistry is more important than upbringing. Without
evidence, we withhold judgment.
Advocacy is not the purpose of this book. Rather, we hope it will be
useful in applying current knowledge to those vexatious problems—
crudely defined and poorly understood—that come within the jurisdiction
of psychiatry.
D. W. G.
Saint Louis
December 1973
L O OK I N G F OR WA R D
( xxi )
( xxii ) Looking Forward
this text was the publication of DSM-5 in 2013 (6). DSM-5 was highly
anticipated in 2010 and provided some advances in the criteria for psychi-
atric illnesses, some new illness classifications, and some changes in how
illnesses are categorized. As many in the field thought at the time, DSM-5
is a thoughtful, but incremental, extension of work that originated with
the publication of the Feighner criteria in 1972 (11), the first edition of
Psychiatric Diagnosis in 1974 (22), and DSM-III in 1980 (2). Unfortunately,
DSM-5, while useful, has not fundamentally altered conceptualization of
psychiatric illnesses and may be viewed as a relatively small step forward for
the field, remaining consistent with traditional categorical descriptions of
disorders. Categorical approaches remain extremely helpful for clinicians,
and psychiatric categorical diagnoses can be applied highly reliably, con-
sistent with other recent editions of the DSM. As noted in all editions of
this book, validation of the major psychiatric syndromes remains problem-
atic and is largely based on clinical criteria initially developed in the 1970s
(18). The field continues to lack mechanistic explanations and meaningful
biomarkers.
In parallel to DSM-5, other attempts have considered psychiatric
symptoms from dimensional perspectives, in which specific symptoms and
traits are viewed as being continuously distributed in the population with
disorders representing far ends of the distribution spectra. The most notable
example of this approach is found in the Research Domain Criteria (RDoC)
project, launched by the National Institute of Mental Health (NIMH) in
2010 (9). RDoC attempts to relate psychiatric symptoms more closely to
advances in brain science and in understanding brain systems that likely
underlie these symptoms. This has had a significant impact on research
(as would be expected from an NIH-driven initiative), but the impact on
psychiatric diagnosis and practice has been much less clear. Nonetheless,
a possible marriage of categorical and dimensional approaches remains
possible and could have a significant impact going forward, particularly as
brain sciences and behavioral genetics continue to evolve.
The past eight years have witnessed major advances in neuroscience
and genetics that hold great, but not yet realized potential for psychi-
atry. In 2009, the first round of the Human Connectome Project (HCP)
was launched. This project sought to map functional connectivity neural
networks in the normal human adult brain using an array of sophisticated
imaging and neuroscience tools, including state-of-the-art functional con-
nectivity magnetic resonance neuroimaging (fcMRI) and sophisticated
analytical methods based on graph theory and network analysis (12).
HCP provides important information about the brain networks that can
be identified in humans, networks that underlie cognition, perception,
Looking Forward ( xxiii )
emotion and motivation, key components of the human mind, and aspects
of information processing that are altered in all major psychiatric illnesses.
HCP is being extended across the human lifespan and will continue to pro-
duce major new insights into how the brain functions in health and illness.
A major challenge going forward concerns how to relate the under-
standing that has derived from studies of relatively large groups of
individuals to the connectomes of individual humans (13), particularly
those with psychiatric illnesses. Again, progress is being made in this
arena, but it is still not possible to use fcMRI for diagnostic purposes at
the level of individual patients. This latter situation could change dra-
matically before the next editions of Psychiatric Diagnosis and the DSM
are published. Already, significant inroads are being made in using con-
nectivity neuroimaging to subclassify groups of patients with major
depression and other illnesses and to make predictions about possible
treatments targeted to illness subtypes (10). This work will undoubtedly
continue to advance over the next decade and continues to hold great
promise for the field.
While advances in human neuroscience have been dramatic over the
past eight years, they arguably pale in comparison to the accomplishments
in preclinical neuroscience. Neuroscientists now have at their disposal an
array of highly sophisticated methodologies to probe the activity of cells
and networks of cells in live animals as they perform a variety of behaviors
likely related to psychiatric symptoms and syndromes. These techniques
include ways to manipulate the expression of specific genes using CRISPR-
Cas9 gene editing technology (Clustered Regularly Interspersed Short
Palindromic Repeats) (16), the ability to study the anatomy of circuits in
exquisite detail using CLARITY methods (7), and the ability to manipu-
late the activity of neurons and others cells within neural circuits using
optogenetics and visible light pulses to activate ion channels and other
proteins expressed in specific brain cells (15). This work has advanced
greatly in recent years, and studies using these methods are now routinely
conducted in major neuroscience laboratories around the world. Studies
using these methods have provided new insights into how the mamma-
lian brain processes information, how emotions are coded in the brain,
and how specific neural circuits underlie motivated behavior. Coupled
with these methods have been advances in animal behavioral studies, in-
cluding models of animal behavior that may have relevance for psychiatric
disorders. As with human neuroscience, studies using these methods and
derivatives of these methods are in their infancy, although progress is being
made rapidly. How these studies in animals, particularly in rodent models,
translate into insights about human disorders and into new treatments
( xxiv ) Looking Forward
REFERENCES
17. Mistry, S., Harrison, J. R., Smith, D. J., Escott-Price, V., and Zammit, S. The use of
polygenic risk scores to identify phenotypes associated with genetic risk of bipolar
disorder and depression: a systematic review. J. Affect. Disord., 234:148–155, 2018.
18. Robins, E., and Guze, S. B. Establishment of diagnostic validity in psychiatric ill-
ness: its application to schizophrenia. Am. J. Psychiatry, 126:983–987, 1970.
19. Sekar, A., Bielar, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N.,
Tooley, K., Presumey, J., Baum, M., Van Doren, V., Genovese, J., Rose, S. A.,
Handsaker, R. E., Daly, M. J., Carroll, M. C., Stevens, B., and McCarroll, S. A.
Schizophrenia risk from complex variation of complement component 4. Nature,
530:177–183, 2016.
20. Shinn, M., Knickman, J. R., and Weitzman, B. C. Social relationships and
vulnerability to becoming homeless among poor families. Am. Psychol.,
46(11):1180–1187, 1991.
21. Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D.,
Ghandour, R. M., Perou, R., and Blumberg, S. J. Trends in the parent-report of
health care provider- diagnosed and medicated attention- deficit/
hyperactivity
disorder: United States, 2003– 2011. J. Am. Acad. Child Adolesc. Psychiatry,
53:34–46, 2014.
22. Woodruff, R. A., Jr., Goodwin, D. W., and Guze, S. B. Psychiatric Diagnosis.
New York: Oxford University Press, 1974.
23. Zorumski, C. F., and Conway, C. R. Use of ketamine in clinical practice: a time for
optimism and caution. JAMA Psychiatry, 74:405–406, 2017.
Goodwin and Guze’s Psychiatric Diagnosis
CHAPTER 1
w
Evolution of Psychiatric Diagnosis
(1)
(2) Goodwin and Guze’s Psychiatric Diagnosis
the disease concept for mental illness—but again without explicit criteria.
Diagnostic reliability was not yet a feature of the proffered labels. To find
its place among the medical sciences, psychiatry needed to develop an epi-
demiological system for classifying disease, known as “nosology” (35).
Several European physicians specializing in problems of psychi-
atry (Kraepelin, Kahlbaum, Bleuler, and others) who predated or were
contemporaries of Freud found it more useful to describe the phenome-
nology of mental illness as clustering in “syndromes” according to their
unique symptoms, course, and outcome over time. These physicians
followed an earlier and evolving approach to disease initiated by Sydenham
in the late 1600s and further developed over the centuries by Koch,
Pasteur, Virchow, and others. The relevant assumption by most of these
investigators was that identification of a syndrome would lead to a better
understanding of the illness and possibly etiology. Kraepelin considered
mental disorders to be commensurate with physical diseases. He followed
medical traditions of careful observation of many cases to describe overt
characteristics of illness, rather than relying on unproven etiological
theories. Kraepelin predicted that empirical research would eventually pro-
vide evidence of biological origins of mental illness (45, 51).
The classification/diagnostic approach and attendant scientific methods
were not systematically applied in American psychiatry until the advent of
the “descriptive school” in the latter half of the twentieth century, whose
traditions were founded on the earlier work of Sydenham, Kraepelin, and
others. During the 1960s and early 1970s, the Washington University
group in St. Louis, described as “an outpost of diagnostically oriented
thinking” (p. 259) (45), refined the descriptive approach to psychiatry and
distinguished themselves as radically different from the prevailing psycho-
analytic school. In American psychiatry at that time, the belief that mental
disorders were a subset of medical disorders was controversial (45) if not
heretical. Members of this group, often referred to as “neo-Kraepelinians,”
were described by some as “organic” or “biological” in orientation, but their
position regarding the origin of symptoms was simply “what the evidence
or reproducible data demonstrated.”
In 1970, Robins and Guze (44), at Washington University in St. Louis,
published their proposal for five phases necessary to establish the va-
lidity and reliability of a psychiatric diagnosis. These phases included the
following:
1. Clinical description. The first step is to describe the clinical picture. Race,
sex, age at onset, precipitating factor(s), and other items may be used to
define characteristics and occurrence of the disorder. The clinical picture
E vol u t i o n of P s yc h i at r i c Di ag n o s i s (3)
Feighner et al., in 1972 (17), outlined the diagnoses and criteria that
met these phases. Included were the following: primary affective disorder
(mania/depression), secondary affective disorder, schizophrenia, anxiety
neurosis, obsessive-compulsive neurosis, phobic neurosis, hysteria, antiso-
cial personality disorder, alcoholism, drug dependence, mental retardation,
organic brain syndrome, anorexia nervosa, and several others. It should be
noted that with the possible exception of brain syndrome(s), laboratory
studies have still not been developed that reproducibly demonstrate path-
ological lesions. However, thoughtful and careful completion, with replica-
tion, of most of the phases (1, 3, 4, and 5) firmly established the bases for
the validity of the major mental illnesses.
To gain a foothold in the published literature, this group published their
early work in diagnostic psychiatry in British and other European litera-
ture, outside the reach of American hostility to their ideas (Samuel B. Guze,
personal communication). In 1974, the first edition of Psychiatric Diagnosis,
co-authored by Robert A. Woodruff, Jr., Donald W. Goodwin, and Samuel
B. Guze, was published by Oxford University Press (50). Although written
for the education of medical students, it became an icon for the field. At
the time, this text was arguably the most authoritative source of diagnostic
psychiatry, as the current diagnostic manual of the APA had not yet incor-
porated empirically based criteria.
In the late 1970s, Robert Spitzer, with remarkable political finesse,
convened meetings of members of the two formal psychiatric schools,
psychoanalytic and evidence-based/biological (45), to generate the third
edition of the Diagnostic and Statistical Manual (DSM-III) (4). The text was
generally intended to be atheoretical in orientation regarding the origin of
most psychopathology. (Of note, to appease an opposition that threatened
to block the document’s approval, the word neurosis, a concept fundamental
(4) Goodwin and Guze’s Psychiatric Diagnosis